included_article_id,GDG,question_id,included_postfulltext,included_reference,same_study_diff_article,notes,author_1_extract,year_pub_extract,author_year_format,included_article_doi,included_article_pmid,oa_id,ss_id,title_if_unavailable,title,pmid_sent,doi_sent,_merge_doi,_merge_pmid,alternate_title2,alternate_title3,api_id_retrieved,author_address,custom1,custom2,custom3,custom4,doi_retrieved,end_page,file_attachments2,first_authors,issn,keywords,language,name_of_database,non_null_count,note,notes_abstract,number,place_published,pmid_retrieved,primary_title,publication_year,publisher,secondary_title,start_page,tertiary_title,type_of_reference,urls,volume,best_match_index,best_match_string,match_string,matching_title_from_embase_results,original_index,similarity_score,api_retrieval_success
4,1,1.2,16,"Khashchenko E, Uvarova E, Vysokikh M, Ivanets T, Krechetova L, Tarasova N, Sukhanova I, Mamedova F, Borovikov P, Balashov I, Sukhikh G. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents. J Clin Med. 2020 Jun 11;9(6):1831. doi: 10.3390/jcm9061831. PMID: 32545404; PMCID: PMC7355484.",primary_citation,,Khashchenko E,2020,"Khashchenko E et al., 2020",10.3390/jcm9061831,32545404,,,,The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents,32545404,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
41,1,"1.4.1, 1.4.2",27,"Kar S, Swoyam S. 2D and 3D trans-vaginal sonography to determine cut-offs for ovarian volume and follicle number per ovary for diagnosis of polycystic ovary syndrome in Indian women. J Reprod Infertil 2018;19:146–151. ",primary_citation,,Kar S,2018,"Kar S et al., 2018",,30167395,,,,2D and 3D Trans-vaginal Sonography to Determine Cut-offs for Ovarian Volume and Follicle Number per Ovary for Diagnosis of Polycystic Ovary Syndrome in Indian Women,30167395,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
54,1,"1.5.1, 1.5.2",53,"Agrawal, N.; Sharma, R. Correlation of anti-müllerian hormone with clinical, hormonal and ultrasonographic parameters in pcos and normo-ovulatory women: An experience of single tertiary care center. Ital J Gynaecol Obstet 2018;30(4):37-43.",primary_citation,,Agrawal,2018,"Agrawal et al., 2018",10.9790/0853-1602085156,,,52258305,,"Correlation of Anti-Mullerian Hormone with clinical, hormonal and ultrasonographic parameters in PCOS and normo-ovulatory women",,10.9790/0853-1602085156,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
55,1,"1.5.1, 1.5.2",53,"Ahmed N, Batarfi AA, Bajouh OS, Bakhashab S. Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms. Diagnostics (Basel). 2019 Oct 1;9(4):136. doi: 10.3390/diagnostics9040136. PMID: 31581541; PMCID: PMC6963945.",primary_citation,,Ahmed N,2019,"Ahmed N et al., 2019",10.3390/diagnostics9040136,31581541,,,,Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms,31581541,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
56,1,"1.5.1, 1.5.2",53,"Al-Jefout M, Alnawaiseh C, Saleh M, Warwar K. Anti-Müllerianhormone (AMH) new cutoff as a possible tool for thediagnosis of polycystic ovary syndrome (PCOS). J Biomed Sci Res. 2021;3(2):139. Doi: 10.36266/JBSR/139.",primary_citation,,Al-Jefout M,2021,"Al-Jefout M et al., 2021",,,,,,Anti-Mullerian hormone (AMH) new cutoff as a possible tool for thediagnosis of polycystic ovary syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
59,1,"1.5.1, 1.5.2",53,"Bakeer E, Radwan R, El Mandoury A, El Rahman AA, Gad M, El Maksoud SA. Anti-Müllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters. J Med Biochem. 2018 Dec 1;37(4):448-455. doi: 10.1515/jomb-2017-0068. PMID: 30584404; PMCID: PMC6298483.",primary_citation,,Bakeer E,2018,"Bakeer E et al., 2018",10.1515/jomb-2017-0068,30584404,,,,"Anti-Müllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters",30584404,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
66,1,"1.5.1, 1.5.2",53,"Deveer M, Deveer R, Basaran O, Turkcu UO, Akbaba E, Cullu N, Turhan N, Kucuk M, Kasap B. Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome. J Clin Med Res. 2015 Dec;7(12):989-94. doi: 10.14740/jocmr2375w. Epub 2015 Oct 23. PMID: 26566413; PMCID: PMC4625820.",primary_citation,,Deveer M,2015,"Deveer M et al., 2015",10.14740/jocmr2375w,26566413,,,,"Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome",26566413,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
71,1,"1.5.1, 1.5.2",53,"Gabr H, Marei ES, The Relation between Anti-Mullerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome. Arab Journal of Nuclear Sciences and Applications 2019;52(2):84-93. ",primary_citation,,Gabr H,2019,"Gabr H et al., 2019",10.21608/ajnsa.2019.3711.1087,,,,,Relation between Anti-Müllerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome,,10.21608/ajnsa.2019.3711.1087,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
74,1,"1.5.1, 1.5.2",53,"Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch Gynecol Obstet. 2016 Feb;293(2):447-56. doi: 10.1007/s00404-015-3889-5. Epub 2015 Sep 25. PMID: 26408006.",primary_citation,,Jamil AS,2016,"Jamil AS et al., 2016",10.1007/s00404-015-3889-5,26408006,,,,Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria,26408006,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
76,1,"1.5.1, 1.5.2",53,"Khashchenko E, Uvarova E, Vysokikh M, Ivanets T, Krechetova L, Tarasova N, Sukhanova I, Mamedova F, Borovikov P, Balashov I, Sukhikh G. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents. J Clin Med. 2020 Jun 11;9(6):1831. doi: 10.3390/jcm9061831. PMID: 32545404; PMCID: PMC7355484.",primary_citation,,Khashchenko E,2020,"Khashchenko E et al., 2020",10.3390/jcm9061831,32545404,,,,The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents,32545404,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
83,1,"1.5.1, 1.5.2",53,"Mahajan N, Kaur J. Establishing an Anti-Müllerian Hormone Cutoff for Diagnosis of Polycystic Ovarian Syndrome in Women of Reproductive Age-Bearing Indian Ethnicity Using the Automated Anti-Müllerian Hormone Assay. J Hum Reprod Sci. 2019 Apr-Jun;12(2):104-113. doi: 10.4103/jhrs.JHRS_149_18. PMID: 31293324; PMCID: PMC6594116.",primary_citation,,Mahajan N,2019,"Mahajan N et al., 2019",10.4103/jhrs.jhrs_149_18,31293324,,,,Establishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay,31293324,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
96,1,"1.5.1, 1.5.2",53,"Singh S, Firdaus A, Choudhary R, Dhama V. Role of antimullerian hormone as a diagnostic tool for polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol. 2020;9(9):3730. DOI: 10.18203/2320-1770.ijrcog20203847.",primary_citation,,Singh S,2020,"Singh S et al., 2020",10.18203/2320-1770.ijrcog20203847,,,,,Role of anti-mullerian hormone as a diagnostic tool for polycystic ovary syndrome,,10.18203/2320-1770.ijrcog20203847,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
100,1,"1.5.1, 1.5.2",53,"Tola H, Abbas M, Alhassan EA, Shrif NE, Rida M. Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women. Open Access Maced J Med Sci. 2018;6(7):1244-1247. Published 2018 Jul 17.",primary_citation,,Tola H,2018,"Tola H et al., 2018",10.3889/oamjms.2018.260,30087729,,,,"Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women",30087729,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
119,1,1.6,47,"Deswal R, Dang AS, Nanda S. Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women. Indian Journal of Health and Wellbeing. 2014;5(6):742-744.",primary_citation,,Deswal R,2014,"Deswal R et al., 2014",,,W2221924240,,Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women,Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian Women,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
138,1,1.6,47,"Salehpour S, Shirvani HE, Entezari A. Evaluation of the prevalence of polycystic ovarian syndrome among adolescent (15-18 years old) girls in Tehran during 2005-2006. International Journal of Fertility and Sterility. 2010;4(3):122-127.",primary_citation,,Salehpour S,2005,"Salehpour S et al., 2005",10.22074/ijfs.2010.45808,,,,,Evaluation of the Prevalence of Polycystic Ovarian Syndrome among Adolescent (15-18 Years Old) Girls in Tehran during 2005-2006,,10.22074/ijfs.2010.45808,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
143,1,1.6,47,"Dashti S, Latiffah Abdul L, Habibah Abdul H, et al. Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff. Journal of Midwifery & Reproductive Health. 2019;7(1):1560-1568. doi: 10.22038/jmrh.2018.30370.1329",primary_citation,,Dashti S,2019,"Dashti S et al., 2019",10.22038/jmrh.2018.30370.1329,,,,,Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff,,10.22038/jmrh.2018.30370.1329,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
150,1,1.6,47,"Park YJ, Shin H, Jeon S, Cho I, Kim YJ. Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women. Healthcare (Basel). 2021 Jan 7;9(1):56. doi: 10.3390/healthcare9010056. PMID: 33430265; PMCID: PMC7825721.",primary_citation,,Park YJ,2021,"Park YJ et al., 2021",10.3390/healthcare9010056,33430265,,,,Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women,33430265,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
244,1,1.10.,10,"Helvaci N, Karabulut E, Demir AU, Yildiz BO. Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature. Endocr Connect. 2017 Oct;6(7):437-445. doi: 10.1530/EC-17-0129. Epub 2017 Jul 24. PMID: 28739562; PMCID: PMC5574283.",primary_citation,,Helvaci N,2017,"Helvaci N et al., 2017",10.1530/ec-17-0129,28739562,,,,Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature,28739562,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
252,1,1.11,23,"Beavis AL, Najjar O, Cheskin LJ, Mangal R, Rositch AF, Langham G, Fader AN. Prevalence of endometrial cancer symptoms among overweight and obese women presenting to a multidisciplinary weight management center. Gynecol Oncol Rep. 2020 Sep 11;34:100643. doi: 10.1016/j.gore.2020.100643. PMID: 32995455; PMCID: PMC7502818.",primary_citation,,Beavis AL,2020,"Beavis AL et al., 2020",10.1016/j.gore.2020.100643,32995455,,,,Prevalence of endometrial cancer symptoms among overweight and obese women presenting to a multidisciplinary weight management center,32995455,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
254,1,1.11,23,"Elfayomy AK, Soliman BS. Risk Factors Associated with the Malignant Changes of Symptomatic and Asymptomatic Endometrial Polyps in Premenopausal Women. J Obstet Gynaecol India. 2015 May;65(3):186-92. doi: 10.1007/s13224-014-0576-6. Epub 2014 Jun 1. PMID: 26085741; PMCID: PMC4464569.",primary_citation,,Elfayomy AK,2015,"Elfayomy AK et al., 2015",10.1007/s13224-014-0576-6,26085741,,,,Risk Factors Associated with the Malignant Changes of Symptomatic and Asymptomatic Endometrial Polyps in Premenopausal Women,26085741,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
262,1,1.11,23,"Okamura Y, Saito F, Takaishi K, Motohara T, Honda R, Ohba T, Katabuchi H. Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age. Reprod Med Biol. 2016 Dec 5;16(1):67-71. doi: 10.1002/rmb2.12012. PMID: 29259453; PMCID: PMC5715875.",primary_citation,,Okamura Y,2016,"Okamura Y et al., 2016",10.1002/rmb2.12012,29259453,,,,Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age,29259453,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
276,1,1.12,60,"Crisosto N, Echiburú B, Maliqueo M, Luchsinger M, Rojas P, Recabarren S, Sir-Petermann T. Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome. Endocr Connect. 2017 Nov;6(8):607-613. doi: 10.1530/EC-17-0218. Epub 2017 Sep 14. PMID: 28912339; PMCID: PMC5640572. (primary citation)",primary_citation,,Crisosto N,2017,"Crisosto N et al., 2017",10.1530/ec-17-0218,28912339,,,,Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome,28912339,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
277,1,1.12,60,"SIR-PETERMANN, T., VANTMAN, N., CONCHA, F., ECHIBURU, B., PEREIRA, C., DE GUEVARA, A. L., CRISOSTO, N. R., PEREZ-BRAVO, F. A. & SANTOS, J. L. 2014. Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome. Endocr. Rev., 35, 2.",samestudy_276,,SIR-PETERMANN,2014,"SIR-PETERMANN et al., 2014",,,,,Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome,Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
282,1,1.12,60,"Leblanc, S. H., Leblanc, S., Battista, M. C., Geller, D. H., & Baillargeon, J. P. (2016). Evolution of metabolic alterations 5 years after peri-pubertal years in young girls genetically predisposed to polycystic ovary syndrome compared to age-matched control girls. Endocrine Reviews, 37(2 Supplement 1). doi:https://dx.doi.org/10.1210/endo-meetings.2016.RE.5.SUN-156",samestudy_281,,Leblanc,2016,"Leblanc et al., 2016",,,,,,Evolution of metabolic alterations 5 years after peri-pubertal years in young girls genetically predisposed to polycystic ovary syndrome compared to age-matched control girls,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
291,1,1.12,60,"Kulshreshtha B, Sharma N, Pant S, Prasad A, Chitkara A, Pahuja B, Pahuja I. Predictors of Metabolic Syndrome among Polycystic Ovary Syndrome Sisters. J Hum Reprod Sci. 2019 Oct-Dec;12(4):334-340. doi: 10.4103/jhrs.JHRS_172_18. Epub 2019 Dec 17. PMID: 32038085; PMCID: PMC6937762.",primary_citation,,Kulshreshtha B,2019,"Kulshreshtha B et al., 2019",10.4103/jhrs.jhrs_172_18,32038085,,,,Predictors of metabolic syndrome among polycystic ovary syndrome sisters,32038085,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
295,1,1.12,60,"Zhang Z, Liu Y, Lv J, Zhang D, Hu K, Li J, Ma J, Cui L, Zhao H. Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021 Aug 9;12:698734. doi: 10.3389/fendo.2021.698734. PMID: 34434168; PMCID: PMC8380809.",samestudy_294,,Zhang Z,2021,"Zhang Z et al., 2021",10.3389/fendo.2021.698734,34434168,,,,Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome,34434168,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
296,1,1.12,60,"Raissouni N, Kolesnikov A, Purushothaman R, Sinha S, Bhandari S, Bhangoo A, Malik S, Mathew R, Baillargeon JP, Hernandez MI, Rosenbaum M, Ten S, Geller D. Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome. Int J Pediatr Endocrinol. 2012 May 29;2012(1):14. doi: 10.1186/1687-9856-2012-14. PMID: 22643321; PMCID: PMC3477027. (primary citation)",primary_citation,,Raissouni N,2012,"Raissouni N et al., 2012",10.1186/1687-9856-2012-14,22643321,,,,Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome,22643321,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
298,1,1.12,60,"Trottier, A., Battista, M. C., Simoneau-Roy, J., Carpentier, A., Geller, D. H., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in first-degree relative adolescent girls of polycystic ovary syndrome women. Endocrine Reviews, 32(3 Meeting Abstracts). ",samestudy_296,,Trottier,2011,"Trottier et al., 2011",10.1210/endo-meetings.2011.part2.p32.p2-239,,W4253108685,,,Early Metabolic and Endocrine Perturbations in First-Degree Relative Adolescent Girls of Polycystic Ovary Syndrome Women,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
318,1,1.12,60,"Sir-Petermann, T.; Angel, B.; Maliqueo, M.; Perez-Bravo, F. Glucose tolerance, insulin secretion and insulin resistance in parents of women with polycystic ovary sindrome. Diabetologia 2001;44:A86-A86.",samestudy_313,,Sir-Petermann,2001,"Sir-Petermann et al., 2001",10.1007/bf03180172,,,,,"Abstracts of the 37th Annual Meeting of the EASD Glasgow, United Kingdom, 9–13 September 2001",,10.1007/bf03180172,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
324,1,1.12,60,"TORCHEN, L., FOGEL, N. R., BRICKMAN, W., PAPARODIS, R. & DUNAIF, A. 2013. Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study. Endocrine Reviews, 34.",samestudy_323,,TORCHEN,2013,"TORCHEN et al., 2013",,,,,Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study,Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
325,1,1.12,60,"TORCHEN, L. C., FOGEL, N. R., BRICKMAN, W. J., MAURAS, N. & DUNAIF, A. 2012. Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives. Endocrine Reviews, 33.",samestudy_323,,TORCHEN,2012,"TORCHEN et al., 2012",,,,,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
328,1,1.12,60,"Vipin VP, Dabadghao P, Shukla M, Kapoor A, Raghuvanshi AS, Ramesh V. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome. Fertil Steril. 2016 May;105(5):1338-1344.e3. doi: 10.1016/j.fertnstert.2016.01.024. Epub 2016 Feb 4. PMID: 26852421.",primary_citation,,Vipin VP,2016,"Vipin VP et al., 2016",10.1016/j.fertnstert.2016.01.024,26852421,,,,Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome,26852421,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
338,2,2.1.1 / 2.1.2,36,"Donbaloglu, Z.; Tuhan, H.; Coban, O. G.; Kizilay, D. O.; Ismailoglu, E.; Onder, A.; Acar, S.; Bedel, A.; Cetiner, E. B.; Singin, B.; Erdem, H.; Parlak, M. Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome. Clinical Pediatric Endocrinology 05 Apr 2022;31(2)():68-76 2022 05 Apr",primary_citation,,Donbaloglu,2022,"Donbaloglu et al., 2022",10.1297/cpe.2022-0010,,,,,Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome,35431449,10.1297/cpe.2022-0010,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
367,2,2.1.1 / 2.1.2,36,"Shafti, V. and S. Shahbazi (2016). ""Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women."" Journal of Family & Reproductive Health 10(2): 92-98.",primary_citation,prior search,Shafti,2016,"Shafti et al., 2016",,27648099,W2517888967,8524156,,Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women.,27648099,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
378,2,2.2,80,"Annagür BB, Tazegül A, Akbaba N. Body Image, Self-Esteem and Depressive Symptomatology in Women with Polycystic Ovary Syndrome. Noro Psikiyatr Ars. 2014 Jun;51(2):129-132. doi: 10.4274/npa.y6778. Epub 2014 Jun 1. PMID: 28360612; PMCID: PMC5353087.",primary_citation,,Annagür BB,2014,"Annagür BB et al., 2014",10.4274/npa.y6778,28360612,,,,"Polikistik Over Sendromu Olan Kadınlarda Beden Algısı, Benlik Saygısı ve Depresif Belirtiler",28360612,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
381,2,2.2,80,"Balikci A, Erdem M, Keskin U, Bozkurt Zincir S, Gülsün M, Özçelik F, Akgül EÖ, Akarsu S, Öztosun M, Ergün A. Depression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome. Noro Psikiyatr Ars. 2014 Dec;51(4):328-333. doi: 10.5152/npa.2014.6898. Epub 2014 Dec 1. PMID: 28360650; PMCID: PMC5353166.",primary_citation,,Balikci A,2014,"Balikci A et al., 2014",10.5152/npa.2014.6898,28360650,,,,"Depression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome",28360650,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
384,2,2.2,80,"Basirat Z, Faramarzi M, Esmaelzadeh S, Abedi Firoozjai SH, Mahouti T, Geraili Z. Stress, Depression, Sexual Function, and Alexithymia in Infertile Females with and without Polycystic Ovary Syndrome: A Case-Control Study. Int J Fertil Steril. 2019 Oct;13(3):203-208. doi: 10.22074/ijfs.2019.5703. Epub 2019 Jul 14. PMID: 31310074; PMCID: PMC6642420.",primary_citation,,Basirat Z,2019,"Basirat Z et al., 2019",10.22074/ijfs.2019.5703,31310074,,,,"Stress, Depression, Sexual Function, and Alexithymia in Infertile Females with and without Polycystic Ovary Syndrome: A Case-Control Study.",31310074,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
397,2,2.2,80,"Donbaloğlu Z, Tuhan H, Çoban ÖG, Kızılay DÖ, İsmailoğlu E, Önder A, Acar S, Bedel A, Çetiner EB, Singin B, Erdem H, Parlak M. Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome. Clin Pediatr Endocrinol. 2022;31(2):68-76. doi: 10.1297/cpe.2022-0010. Epub 2022 Mar 19. PMID: 35431449; PMCID: PMC8981047.",primary_citation,,Donbaloğlu Z,2022,"Donbaloğlu Z et al., 2022",10.1297/cpe.2022-0010,35431449,,,,Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome,35431449,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
401,2,2.2,80,"Enjezab B, Eftekhar M, Ghadiri-Anari A. Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome. Electron Physician. 2017 Nov 25;9(11):5820-5825. doi: 10.19082/5820. PMID: 29403625; PMCID: PMC5783134.",primary_citation,,Enjezab B,2017,"Enjezab B et al., 2017",10.19082/5820,29403625,,,,Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome,29403625,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
412,2,2.2,80,"Hussain A, Chandel RK, Ganie MA, Dar MA, Rather YH, Wani ZA, Shiekh JA, Shah MS. Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in kashmir. Indian J Psychol Med. 2015 Jan-Mar;37(1):66-70. doi: 10.4103/0253-7176.150822. PMID: 25722515; PMCID: PMC4341314.",primary_citation,,Hussain A,2015,"Hussain A et al., 2015",10.4103/0253-7176.150822,25722515,,,,Prevalence of Psychiatric Disorders in Patients with a Diagnosis of Polycystic Ovary Syndrome in Kashmir,25722515,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
425,2,2.2,80,"Mehrabadi S, Sadatmahalleh SJ, Kazemnejad A, Moini A. Association of acne, hirsutism, androgen, anxiety, and depression on cognitive performance in polycystic ovary syndrome: A cross-sectional study. Int J Reprod Biomed. 2020 Dec 21;18(12):1049-1058. doi: 10.18502/ijrm.v18i12.8026. PMID: 33426415; PMCID: PMC7778752.",primary_citation,,Mehrabadi S,2020,"Mehrabadi S et al., 2020",10.18502/ijrm.v18i12.8026,33426415,,,,"Association of acne, hirsutism, androgen, anxiety, and depression on cognitive performance in polycystic ovary syndrome: A cross-sectional study",33426415,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
429,2,2.2,80,"Mukundan, A., & Jayakumari, S. (2019). RISK OF DEVELOPING DEPRESSION AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME - A SOUTH INDIAN SCENARIO. International Journal Of Pharmaceutical Sciences And Research, 10(6), 2956-2961.",primary_citation,,Mukundan,2019,"Mukundan et al., 2019",10.13040/ijpsr.0975-8232.10(6).2956-61,,,212468337,,RISK OF DEVELOPING DEPRESSION AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME-A SOUTH INDIAN SCENARIO,,10.13040/ijpsr.0975-8232.10(6).2956-61,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
432,2,2.2,80,"Ozenli, Y., Haydardedeoglu, B., Micozkadioglu, I., Simsek, E., Bulgan Kilicdag, E., & Bagis, T. (2008). Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study. J Turkish-German Gynecol Assoc, 9(4), 190-194.",primary_citation,,Ozenli,2008,"Ozenli et al., 2008",,,,146131120,"Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study","Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
437,2,2.2,80,"Sayyah-Melli M, Alizadeh M, Pourafkary N, Ouladsahebmadarek E, Jafari-Shobeiri M, Abbassi J, Kazemi-Shishvan MA, Sedaghat K. Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study. J Caring Sci. 2015 Sep 1;4(3):225-31. doi: 10.15171/jcs.2015.023. PMID: 26464839; PMCID: PMC4591610.",primary_citation,,Sayyah-Melli M,2015,"Sayyah-Melli M et al., 2015",10.15171/jcs.2015.023,26464839,,,,Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study,26464839,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
442,2,2.2,80,"Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, Waly MI, Saleh J, Al-Adawi S. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Womens Health. 2017 Dec 12;9:897-904. doi: 10.2147/IJWH.S145383. PMID: 29276413; PMCID: PMC5731436.",primary_citation,,Sulaiman MA,2017,"Sulaiman MA et al., 2017",10.2147/ijwh.s145383,29276413,,,,Psychological burden among women with polycystic ovarian syndrome in Oman: a case&amp;ndash;control study,29276413,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
444,2,2.2,80,"Tseng PH, Chiu HM, Tu CH, Wu MS, Ho HN, Chen MJ. Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021 Nov 16;12:779456. doi: 10.3389/fendo.2021.779456. PMID: 34867827; PMCID: PMC8635163.",primary_citation,,Tseng PH,2021,"Tseng PH et al., 2021",10.3389/fendo.2021.779456,34867827,,,,Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome,34867827,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
454,2,2.3,29,"Elkhiat, Y., Zedan, A., Mostafa, M. and Elhalwagi, A., (2015). Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome. Human Andrology. 2015; 5(3):49-57. DOI:10.1097/01.XHA.0000470182.71509.1b",primary_citation,prior search,Elkhiat,2015,"Elkhiat et al., 2015",10.1097/01.xha.0000470182.71509.1b,,,,,Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome,,10.1097/01.xha.0000470182.71509.1b,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
458,2,2.3,29,"Gateva, A. and Kamenov, Z., (2012). Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment. Advances in Sexual Medicine. 2012.  DOI: 10.4236/asm.2012.22005.",primary_citation,prior search,Gateva,2012,"Gateva et al., 2012",10.4236/asm.2012.22005,,,,,Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment,,10.4236/asm.2012.22005,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
464,2,2.3,29,"Shafti, V. and Shahbazi, S., (2016). Comparing sexual function and quality of life in polycystic ovary syndrome and healthy women. J Fam Reprod Health. 2016; 10, 92-98.",primary_citation,prior search,Shafti,2016,"Shafti et al., 2016",,27648099,W2517888967,8524156,,Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women.,27648099,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
468,2,2.3,29,"Akbari Sene A, Tahmasbi B, Keypour F, Zamanian H, Golbabaei F, Amini-Tehrani M. (2021) Differences in and correlates of sexual function in infertile women with and without polycystic ovary syndrome. Int J Fertil Steril. 2021; 15(1): 65-72. doi: 10.22074/IJFS.2021.6206.",primary_citation,,Akbari Sene A,2021,"Akbari Sene A et al., 2021",10.22074/ijfs.2021.6206,,,,,Differences in and Correlates of Sexual Function in Infertile Women with and without Polycystic Ovary Syndrome.,33497050,10.22074/ijfs.2021.6206,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
493,2,2.5,14,"Lee, I., Cooney, L., Saini, S., Smith, M., Allison, K. Dokras, A. (2016). Increased risk of eating disorders in women with polycystic ovary syndrome. Fertility and Sterility, 2016.",primary_citation,Prior search,Lee,2016,"Lee et al., 2016",10.1016/j.fertnstert.2016.07.750,,,,,Increased risk of eating disorders in women with polycystic ovary syndrome,,10.1016/j.fertnstert.2016.07.750,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
497,2,2.5,14,"Maher, M., Sanders, A.(2018). Eating indicators in women with polycystic ovary syndrome and weight-matched controls. FASEB Journal, 2018.",primary_citation,,Maher,2018,"Maher et al., 2018",10.1096/fasebj.31.1_supplement.lb374,,,,,Eating Indicators In Women With Polycystic Ovary Syndrome And Weight‐Matched Controls,,10.1096/fasebj.31.1_supplement.lb374,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
501,2,2.5,14,"Asdaq, S., Jomah, S., Hasa, R., Al-Baroundi, D., Alharbi, M., Alsubaie, S., Buhamad, M., Alyahya, B., Al-Yamani, MM. (2020). Impact of polycystic ovary syndrome on eating behavior, depression, and health related quality of life: A cross-sectional study in Riyadh. Saudi J Biol Sci, 2020.",primary_citation,,Asdaq,2020,"Asdaq et al., 2020",10.1016/j.sjbs.2020.08.039,,,,,"Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh",33304140,10.1016/j.sjbs.2020.08.039,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
542,2,2.6.1,41,"Williams S, Sheffield D, Knibb RC. â€˜Everythingâ€™s from the inside out with PCOSâ€™: Exploring womenâ€™s experiences of living with polycystic ovary syndrome and co-morbidities through Skypeâ„¢ interviews. Health psychology open. 2015 Aug 28;2(2):2055102915603051.",primary_citation,,Williams S,2015,"Williams S et al., 2015",10.1177/2055102915603051,,,,,‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews,28070371,10.1177/2055102915603051,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
553,2,2.6.4,28,"Crete J, Adamshick P. Managing polycystic ovary syndrome: what our patients are telling us. Journal of Holistic Nursing. 2011 Dec;29(4):256-66.",primary_citation,,Crete J,2011,"Crete J et al., 2011",10.1177/0898010111429092,,,,,Continuing Nursing Education for “Managing Polycystic Ovary Syndrome: What Our Patients Are Telling Us”,,10.1177/0898010111429092,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
562,2,2.6.4,28,"Kitzinger C, Willmott J. ‘The thief of womanhood’: women's experience of polycystic ovarian syndrome. Social science & medicine. 2002 Feb 1;54(3):349-61.",primary_citation,,Kitzinger C,2002,"Kitzinger C et al., 2002",10.1016/s0277-9536(01)00034-x,,,,,‘The thief of womanhood’: women's experience of polycystic ovarian syndrome,,10.1016/s0277-9536(01)00034-x,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
573,2,2.6.4,28,"Williams S, Sheffield D, Knibb RC. ‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews. Health psychology open. 2015 Aug 28;2(2):2055102915603051.",primary_citation,,Williams S,2015,"Williams S et al., 2015",10.1177/2055102915603051,,,,,‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews,28070371,10.1177/2055102915603051,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
596,3,3.1,18,"Saremi A, Nader, Karmali M, Kazemi M. Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial. Iranian Journal of Obstetrics, Gynecology and Infertility 2013;16(64):10.",primary_citation,prior search,Saremi A,2013,"Saremi A et al., 2013",,,W3121804787,, Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial.,Serum level of anti-mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomized controlled trial.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
598,3,3.1,18,"Turan V, Mutlu EK, Solmaz U, Ekin A, Tosun O, Tosun G, et al. Benefits of short‐term structured exercise in non‐overweight women with polycystic ovary syndrome: a prospective randomised controlled study. Journal of Physical Therapy Science 2015;27(7):2293‐7.",primary_citation,prior search,Turan V,2015,"Turan V et al., 2015",10.1589/jpts.27.2293,,,,,Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study,26311969,10.1589/jpts.27.2293,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
605,3,3.3,,"Hoover, S. E., Gower, B. A., Cedillo, Y. E., Chandler-Laney, P. C., Deemer, S. E., & Goss, A. M. (2021). Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS. The Journal of clinical endocrinology and metabolism, 106(5), e2151–e2161. https://doi.org/10.1210/clinem/dgab028",samestudy_604,prior search,Hoover,2021,"Hoover et al., 2021",10.1210/clinem/dgab028,,,,,Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS,33491091,10.1210/clinem/dgab028,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
606,3,3.3,12,"Hosseini Marnani E., Ghadiri-Anari A., Ramezani-Jolfaie N., Mohammadi M., Abdollahi, A., Namayandeh S. M., et al. Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome. Journal of Functional Foods 2020 Vol. 67 Pages 103848. https://doi.org/10.1016/j.jff.2020.103848",primary_citation,,Hosseini Marnani E.,2020,"Hosseini Marnani E. et al., 2020",10.1016/j.jff.2020.103848,,,,,"Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome",,10.1016/j.jff.2020.103848,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
612,3,3.3,12,"Moran, LJ.J., Noakes, M., Clifton, P.M., Tomlinson L., Norman, R. J. (2003). Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 88(2):812–819.",primary_citation,prior search,Moran,2003,"Moran et al., 2003",10.1210/jc.2002-020815,12574218,,,,Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome,12574218,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
614,3,3.3,12,"Panico A, Lupoli GA, Cioffi I, Zacchia G, Caldara A, Lupoli G, Contaldo F, Pasanisi F. Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome. Nutr Ther Metab. 2014;32:85–92.",primary_citation,prior search,Panico A,2014,"Panico A et al., 2014",10.5301/ntm.2014.12407,,,,,Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome,,10.5301/ntm.2014.12407,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
625,3,3.5,70,"Ahmadi A, Akbarzadeh M, Mohammadi F, Akbari M, Jafari B, Tolide-Ie HR. Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. Indian J Endocrinol Metab. 2013 Jul;17(4):672-6. doi: 10.4103/2230-8210.113759. PMID: 23961484; PMCID: PMC3743368.",primary_citation,,Ahmadi A,2013,"Ahmadi A et al., 2013",10.4103/2230-8210.113759,23961484,,,,Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome,23961484,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
630,3,3.5,70,"Arusoglu G,. The Use of SenseWear Armband for Assessment of Daily Energy Expenditure and the Relation to Body Fat Distribution and Nutritional Intake in Lean Women with Polycystic Ovary Syndrome. J Nutr Metab. 2020 May 6;2020:9191505. doi: 10.1155/2020/9191505. PMID: 32455003; PMCID: PMC7225853.",primary_citation,,Arusoglu G,2020,"Arusoglu G et al., 2020",10.1155/2020/9191505,32455003,,,,The Use of SenseWear Armband for Assessment of Daily Energy Expenditure and the Relation to Body Fat Distribution and Nutritional Intake in Lean Women with Polycystic Ovary Syndrome,32455003,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
636,3,3.5,70,"Cutler DA, Pride SM, Cheung AP. Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study. Food Sci Nutr. 2019 Feb 27;7(4):1426-1437. doi: 10.1002/fsn3.977. PMID: 31024716; PMCID: PMC6475723.",primary_citation,,Cutler DA,2019,"Cutler DA et al., 2019",10.1002/fsn3.977,31024716,,,,Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study,31024716,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
642,3,3.5,70,"Forslund M, Landin-Wilhelmsen K, Trimpou P, Schmidt J, Brännström M, Dahlgren E. Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution. Hum Reprod Open. 2020 Jan 15;2020(1):hoz042. doi: 10.1093/hropen/hoz042. PMID: 31976382; PMCID: PMC6964225.",primary_citation,,Forslund M,2020,"Forslund M et al., 2020",10.1093/hropen/hoz042,31976382,,,,Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution,31976382,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
643,3,3.5,70,"Ganie MA, Sahar T, Rashid A, Wani IA, Nisar S, Sathyapalan T, Vishnubhatla S, Ramakrishnan L, Parvez T, Geer I. Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet. Front Endocrinol (Lausanne). 2019 Nov 8;10:699. doi: 10.3389/fendo.2019.00699. PMID: 31781027; PMCID: PMC6857098.",primary_citation,,Ganie MA,2019,"Ganie MA et al., 2019",10.3389/fendo.2019.00699,31781027,,,,Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet,31781027,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
644,3,3.5,70,"Pourghassem Gargari B, Houjeghani S, Farzadi L, Houjeghani S, Safaeiyan A. Relationship between Serum Leptin, Ghrelin and Dietary Macronutrients in Women with Polycystic Ovary Syndrome. Int J Fertil Steril. 2015 Oct-Dec;9(3):313-21. doi: 10.22074/ijfs.2015.4546. Epub 2015 Oct 31. PMID: 26644854; PMCID: PMC4671384.",primary_citation,,Pourghassem Gargari B,2015,"Pourghassem Gargari B et al., 2015",10.22074/ijfs.2015.4546,26644854,,,,"Relationship between Serum Leptin, Ghrelin and Dietary Macronutrients in Women with Polycystic Ovary Syndrome.",26644854,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
645,3,3.5,70,"Gopalan U , Ghose S , Karnaboopathy R , Comparison of dietary pattern and BMI in South Indian women with PCOS and controls. Indian J Obstet Gynecol Res 2021;8(1):57-60",primary_citation,,Gopalan U ,2021,"Gopalan U  et al., 2021",10.18231/j.ijogr.2021.011,,,,,Comparison of dietary pattern and BMI in South Indian women with PCOS and controls,,10.18231/j.ijogr.2021.011,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
648,3,3.5,70,"Hosseini MS, Dizavi A, Rostami H, Parastouei K, Esfandiari S. Healthy eating index in women with polycystic ovary syndrome: A case-control study. Int J Reprod Biomed. 2017 Sep;15(9):575-582. PMID: 29662966; PMCID: PMC5894473.",primary_citation,,Hosseini MS,2017,"Hosseini MS et al., 2017",,29662966,,,,Healthy eating index in women with polycystic ovary syndrome: A case-control study.,29662966,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
649,3,3.5,70,"Huijgen NA, Laven JS, Labee CT, Louwers YV, Willemsen SP, Steegers-Theunissen RP. Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity? PLoS One. 2015 Nov 16;10(11):e0142772. doi: 10.1371/journal.pone.0142772. PMID: 26569630; PMCID: PMC4646482.",primary_citation,,Huijgen NA,2015,"Huijgen NA et al., 2015",10.1371/journal.pone.0142772,26569630,,,,Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?,26569630,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
652,3,3.5,70,"Khademi A, Alleyassin A, Aghahosseini M, Tabatabaeefar L, Amini M. The Effect of Exercise in PCOS Women Who Exercise Regularly. Asian J Sports Med. 2010 Mar;1(1):35-40. doi: 10.5812/asjsm.34874. PMID: 22375190; PMCID: PMC3289164.",primary_citation,,Khademi A,2010,"Khademi A et al., 2010",10.5812/asjsm.34874,22375190,,,,The Effect of Exercise in PCOS Women Who Exercise Regularly,22375190,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
671,3,3.5,70,"Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls. Glob J Health Sci. 2016 Sep 1;8(9):54801. doi: 10.5539/gjhs.v8n9p302. PMID: 27157182; PMCID: PMC5064084.",primary_citation,,Shishehgar F,2016,"Shishehgar F et al., 2016",10.5539/gjhs.v8n9p302,27157182,,,,Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls,27157182,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
672,3,3.5,70,"Shishehgar F, Tehrani FR, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women. Glob J Health Sci. 2016 Oct 1;8(10):56382. doi: 10.5539/gjhs.v8n10p127. PMID: 27302456.",primary_citation,,Shishehgar F,2016,"Shishehgar F et al., 2016",10.5539/gjhs.v8n10p127,27302456,,,,Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women,27302456,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
676,3,3.5,70,"Thara, C., & Divakar, S. U. M. A. (2017). Assessment of nutritional status of PCOS women in Kerala. International Journal of Applied Home Science, 4(9-10), 717-722.",primary_citation,,Thara,2017,"Thara et al., 2017",,,,,Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial,Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
696,3,3.6,7,"Chopra, S., Zehrung, R., Shanmugam, T. A., & Choe, E. K. (2021, May). Living with uncertainty and stigma: self-experimentation and support-seeking around polycystic ovary syndrome. In Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems (pp. 1-18). https://doi.org/10.1145/3411764. 3445706",primary_citation,,Chopra,2021,"Chopra et al., 2021",10.1145/3411764,,,,,Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems,,10.1145/3411764,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
724,4,4.2 / 4.3,85,"Fonseka S, Wijeyaratne CN, Gawarammana IB, Kalupahana NS, Rosairo S, Ratnatunga N, et al. Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study. J Clin Aesthet Dermatol. 2020;13(7):18-23.",primary_citation,,Fonseka S,2020,"Fonseka S et al., 2020",,32983332,W3088805748,222155349,,"Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study.",32983332,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
747,4,4.2 / 4.3,85,"Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KVS. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome. J Family Med Prim Care. 2018;7(3):551-6.",primary_citation,,Kumar Y,2018,"Kumar Y et al., 2018",10.4103/jfmpc.jfmpc_83_17,,,,,"A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome",30112307,10.4103/jfmpc.jfmpc_83_17,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
802,4,4.4,111,"Moghetti, P., et al. Metformin effects on clinical features, endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6 month trial, followed by open, long-term clinical evaluation. Journal of Clinical Endocrinology & Metabolism, 2000. 85(1):139-46. (ROB included in last TR under Patel 2017) ",primary_citation,,Moghetti,2000,"Moghetti et al., 2000",10.1097/00006254-200006000-00019,,,,,"Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, Followed by Open, Long-Term Clinical Evaluation",,10.1097/00006254-200006000-00019,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
815,4,4.4,111,"Fonseka, Sanjeewani; Wijeyaratne, Chandrika N.; Gawarammana, Indika B.; Kalupahana, Nishan S.; Rosairo, Shanthini; Ratnatunga, Neelakanthi; Kumarasiri, Ranjith. Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study, Journal of Clinical & Aesthetic Dermatology 2020",primary_citation,,Fonseka,2020,"Fonseka et al., 2020",,32983332,,222155349,,"Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study.",32983332,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
816,4,4.4,111,"Glintborg, D.; Mumm, H.; Holst, J. J.; Andersen, M. Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome. Endocrine Connections 2017",primary_citation,,Glintborg,2017,"Glintborg et al., 2017",10.1530/ec-17-0034,28432082,,,,Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome,28432082,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
828,4,4.4,111,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Pakistan Journal of Medical Science 2010",primary_citation,,Aghamohammadzadeh N,2010,"Aghamohammadzadeh N et al., 2010",,,,54806151,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
834,4,4.4,111,"Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KV. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome. Journal of Family Medicine and Primary Care 2018 ",primary_citation,,Kumar Y,2018,"Kumar Y et al., 2018",10.4103/jfmpc.jfmpc_83_17,,,,,"A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome",30112307,10.4103/jfmpc.jfmpc_83_17,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
873,4,4.4,111,"Amiri, M., et al., Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese/overweight PCOS women under hypocaloric diet. Journal of Reproduction and Infertility, 2014. 15(4): p. 205‐13. ",primary_citation,,Amiri,2014,"Amiri et al., 2014",,25473629,W2141923412,2675980,,Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet.,25473629,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
878,4,4.4,111,"Diri, H.; Bayram, F.; Simsek, Y.; Caliskan, Z.; Kocer, D. Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in Pcos. Acta Endocrinol (Buchar) Jan-Mar 2017;13(1):84-89",primary_citation,,Diri,2017,"Diri et al., 2017",10.4183/aeb.2017.84,,,,,"Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS",31149153,10.4183/aeb.2017.84,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
890,4,4.4,111,"Shahebrahimi K, Jalilian N, Bazgir N, Rezaei M. Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016 ",primary_citation,,Shahebrahimi K,2016,"Shahebrahimi K et al., 2016",10.4103/2230-8210.192925,,,,,Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome,27867884,10.4103/2230-8210.192925,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
897,4,4.4,111,"Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pfützner A. Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2007",primary_citation,,Steiner CA,2007,"Steiner CA et al., 2007",10.1177/193229680700100212,,,,,Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome,19888409,10.1177/193229680700100212,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
916,4,4.6,26,"Amiri M, Golsorkhtabaramiri M, Esmaeilzadeh S, Ghofrani F, Bijani A, Ghorbani L, Delavar MA. Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet. J Reprod Infertil 2014;15(4):205-13.",primary_citation,,Amiri M,2014,"Amiri M et al., 2014",,25473629,W2141923412,2675980,,Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet.,25473629,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
942,4,4.7,29,"Angik, Riju, Shubhada S. Jajoo, C. Hariharan, and Amogh Chimote. 2017. “A Comparative Study of Metabolic and Hormonal Effects of Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomised Controlled Trial.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 4, No 1 (2015): January-February 2015. https://www.ijrcog.org/index.php/ijrcog/article/view/1838/1588.
",primary_citation,,Angik,2017,"Angik et al., 2017",10.5455/2320-1770.ijrcog20150234,,,,,A COMPARATIVE STUDY OF METABOLIC AND HORMONAL EFFECTS OF MYOINOSITOL VS METFORMIN IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: A RANDOMISED CONTROLLED TRIAL,,10.5455/2320-1770.ijrcog20150234,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
944,4,4.7,29,"Bahadur, Anupama, Hitanshi Arora, Anoosha K Ravi, Manisha Naithani, Yogesh Bahurupi, Jaya Chaturvedi, Megha Ajmani, and Rajlaxmi Mundhra. 2021. “Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.” Cureus 13 (6): e15510. https://doi.org/10.7759/cureus.15510.
",primary_citation,,Bahadur,2021,"Bahadur et al., 2021",10.7759/cureus.15510,,,,,"Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial",34268040,10.7759/cureus.15510,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
946,4,4.7,29,"Chirania, Kishan, Sujata Misra, and Sandhya Behera. 2017. “A Randomised Clinical Trial Comparing Myoinositol and Metformin in PCOS.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 6, No 5 (2017): May 2017DO  - 10.18203/2320-1770.Ijrcog20171563. https://www.ijrcog.org/index.php/ijrcog/article/view/2671.
",primary_citation,,Chirania,2017,"Chirania et al., 2017",10.18203/2320-1770.ijrcog20171563,,,,,A randomised clinical trial comparing myoinositol and metformin in PCOS,,10.18203/2320-1770.ijrcog20171563,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
954,4,4.7,29,"Maria Concetta Musacchio, Vincenzo De Leo. 2013. “A Combined Treatment with Myo-Inositol and Monacolin K Improve the Androgen and Lipid Profiles of Insulin-Resistant PCOS Patients.” J Metabolic Synd 02 (02). https://doi.org/10.4172/2167-0943.1000127.",primary_citation,,Maria Concetta Musacchio,2013,"Maria Concetta Musacchio et al., 2013",10.4172/2167-0943.1000127,,,,,A Combined Treatment with Myo-Inositol and Monacolin K Improve the Androgen and Lipid Profiles of Insulin-Resistant PCOS Patients,,10.4172/2167-0943.1000127,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
956,4,4.7,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut. 2017a. “A Comparative Study of Myo Inositol versus Metformin on Biochemical Profile in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmaceutical Sciences and Research 8 (4): 1664–70. https://doi.org/10.13040/IJPSR.0975-8232.8(4).1664-70. (primary citation)",primary_citation,,Nehra,2017a,"Nehra et al., 2017a",10.13040/ijpsr.0975-8232.8(4).1664-70,,,,, Study of Myo Inositol versus Metformin on Biochemical Profile in Polycystic Ovarian Syndrome in Women,,10.13040/ijpsr.0975-8232.8(4).1664-70,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1016,4,4.10.,109,"Gupta, A.; Raina, K.; Kalkkar, T.; et al. (2009): Pregnancy outcome in women with the polycystic ovarian syndrome. JK Science 11, 2, 82-84, http://www.jkscience.org/archive/vol112/8%20Original%20Article-Pregnancy%20Outcome%20-.pdf",primary_citation,prior search,Gupta,2009,"Gupta et al., 2009",,,W2408925727,59140811,Pregnancy outcome in women with the polycystic ovarian syndrome,Pregnancy Outcome In Women with the Polycystic Ovarian Syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1026,4,4.10.,109,"Mehrabian, F.; Kelishadi, R. (2012): Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls. Journal of Research in Medical Sciences 17, 3, 207-211, http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=23267369",primary_citation,prior search,Mehrabian,2012,"Mehrabian et al., 2012",,,W1953483834,24648982,Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls,Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls.,23267369,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1034,4,4.10.,109,"Foroozanfard, F.; Moosavi, S. G.; Mansouri, F.; et al. (2014): Obstetric and Neonatal Outcome in PCOS with Gestational Diabetes Mellitus. J Family Reprod Health 8, 1, 7-12, http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=24971127",primary_citation,prior search,Foroozanfard,2014,"Foroozanfard et al., 2014",,24971127,,,,Obstetric and Neonatal Outcome in PCOS with Gestational Diabetes Mellitus.,24971127,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1035,4,4.10.,109,"Huang, K.; Dong, X.; Zhang, H.; et al. (2014): Effect of overweight/obesity on IVF-ET outcomes in chinese patients with polycystic ovary syndrome. International Journal of Clinical and Experimental Medicine 7, 12, 5872-5876, http://www.ijcem.com/files/ijcem0003637.pdf",primary_citation,prior search,Huang,2014,"Huang et al., 2014",,25664123,,8327204,,Effect of overweight/obesity on IVF-ET outcomes in chinese patients with polycystic ovary syndrome.,25664123,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1050,4,4.10.,109,"Wang, F.; Dai, W.; Yang, X. H.; et al. (2016): Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China. Sci 6, 34538. https://dx.doi.org/10.1038/srep34538.",primary_citation,prior search,Wang,2016,"Wang et al., 2016",10.1038/srep34538,,,,,Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China,27686055,10.1038/srep34538,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1102,4,4.11,7,"Jamal A, Milani F, Al-Yasin A. Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran J Reprod Med. 2012;10(3):265-270.",primary_citation,,Jamal A,2012,"Jamal A et al., 2012",,25243003,W2147909159,18878695,,Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS.,25243003,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1114,5,5.1,65,"Catak Z, Yavuzkir S, Kocdemir E, Ugur K, Yardim M, Sahin I, et al. NUCB2/nesfatin-1 in the blood and follicular fluid in patients with polycystic ovary syndrome and poor ovarian response. Journal of Reproduction and Infertility. 2019;20(4):225-30.",primary_citation,,Catak Z,2019,"Catak Z et al., 2019",,31897389,W2981960579,204869967,,NUCB2/Nesfatin-1 in the Blood and Follicular Fluid in Patients with Polycystic Ovary Syndrome and Poor Ovarian Response.,31897389,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1147,5,5.1,65,"Madani T, Irani S, Ashrafi M, Alsadat Nabavi M. The Effect of Flutamide on Ovulation Induction in PCOS Patients. International Journal of Fertility & Sterility. 2012;6(1):65-9.",primary_citation,,Madani T,2012,"Madani T et al., 2012",,25505514,,16735901,,The Effect of Flutamide on Ovulation Induction in PCOS Patients.,25505514,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1179,5,5.3,14,"Roy KK, Baruah J, Singla S, Sharma JB, Singh N, Jain SK, Goyal M. A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci. 2012 Jan;5(1):20-5. doi: 10.4103/0974-1208.97789. PMID: 22870010; PMCID: PMC3409915.",primary_citation,,Roy KK,2012,"Roy KK et al., 2012",10.4103/0974-1208.97789,22870010,,,,A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome,22870010,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1209,5,5.4,34,"Roy KK, Baruah J, Singla S, Sharma JB, Singh N, Jain SK, Goyal M. A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci. 2012 Jan;5(1):20-5. doi: 10.4103/0974-1208.97789. PMID: 22870010.",primary_citation,,Roy KK,2012,"Roy KK et al., 2012",10.4103/0974-1208.97789,22870010,,,,A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome,22870010,,,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1234,5,5.7.1,7,"Ashrafi, Mahnaz & Moini, Ashraf & Mohammadzadeh, Afsaneh & Ezabadi, Zahra & Zafarani, Fatemeh & Baghestani, Ahmad. (2005). A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine (ISSN: 1680-6433) Vol 3 Num 1. 3. ",primary_citation,,Ashrafi,2005,"Ashrafi et al., 2005",,,W2162847277,54603939,A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine,A COMPARATIVE STUDY OF GNRH ANTAGONIST AND GNRH AGONIST IN PCO PATIENTS UNDERGOING IVF/ICSI CYCLES,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
1238,5,5.7.1,7,"Kurzawa, R.; Ciepiela, P.; Baczkowski, T.; Safranow, K.; Brelik, P. Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non‐obese patients. A prospective randomized study. J Assist Reprod Genet 2008, 25, 365‐74",primary_citation,,Kurzawa,2008,"Kurzawa et al., 2008",10.1007/s10815-008-9249-7,,,,,Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study,18802744,10.1007/s10815-008-9249-7,left_only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0
